Clinical trial
A Multicenter, Open Label Pilot Study to Explore the Efficacy and Safety of Acthar Gel in Subjects With Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis (NIPPU)
NCT03656692 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open Label Pilot Study to Explore the Efficacy and Safety of Acthar Gel in Subjects With Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis (NIPPU)
- Lead sponsor
- Mallinckrodt
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 5, 2018
- Completion date
- July 14, 2020
- Enrollment
- 5 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.